Animal health Management Leading Conference and Breeding Health Technology Forum

As we all know, the animal insurance industry in my country has been dominated by small and medium-sized enterprises for a long time. Small and scattered is a major feature. With the changes in the breeding structure and consumer demand, the upgrading of my country’s animal insurance industry is imperative. The “new version of veterinary drug GMP” issued last year puts forward higher requirements for the software and hardware standards of animal protection companies. The path for manufacturers to upgrade is “backward integration”- extending to the direction of raw materials upstream of the industrial chain. Due to the higher environmental protection and technical requirements of production materials, and greater project investment, backward integration is the preferred choice for a few companies with strategic vision and economic strength. For most small and medium-sized enterprises, they do not have the ability to choose this kind of choice.

vet medicine

At present, there are still more than 1,700 animal drug companies in our country, most of which are chemical drug companies. Under the dual pressure of industrial policy and market competition, a substantial reduction in chemical drug preparation companies is an inevitable trend in the future. Companies with investment capabilities will be eliminated first.

animal product

During this business school trip, everyone will visit the production workshop of Veyong Pharmaceutical which invested 1 billion Yuan in new APIs in Inner Mongolia. Based on the corporate advantage of the integration of raw materials and preparations, as an industry expert in three fields: “anthelmintic expert”, “intestinal health expert”, and “respiratory expert”, the business school will focus on industry development trends and dig in-depth industry cutting-edge technologies. In-depth exchanges and learning will be conducted on topics such as how to successfully repopulate and accurately remove blue under the background of dual epidemics, resistance reduction and limited resistance, to help the healthy development of China’s breeding industry.


Post time: Jun-19-2021